Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer

T. Andre; C. Sposetti; M. Gumus; J. Bae Ahn; L. Wyrwicz; M. Kwiatkowski; J. Kim; S. Yalcin; M. Sendur; A. Odeleye-Ajakaye; P. Leconte; D. Fogelman; T. Kim

doi:10.1016/j.annonc.2022.04.118

Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer

T. Andre
, C. Sposetti
, M. Gumus
, J. Bae Ahn
, L. Wyrwicz
, M. Kwiatkowski
, J. Kim
, S. Yalcin
, M. Sendur
, A. Odeleye-Ajakaye
, P. Leconte
, D. Fogelman
, T. Kim

Araştırma sonucu: Dergiye katkı › Toplantı Özeti › bilirkişi

Orijinal dil	İngilizce
Sayfa (başlangıç-bitiş)	S256-S257
Sayfa sayısı	2
Dergi	Annals of Oncology
Hacim	33
DOI'lar	https://doi.org/10.1016/j.annonc.2022.04.118
Yayın durumu	Yayınlandı - Haz 2022
Etkinlik	ESMO 24th World Congress on Gastrointestinal Cancer - Barcelona, !!Spain Süre: 29 Haz 2022 → 2 Tem 2022

BM SKH

Bu sonuç, aşağıdaki Sürdürülebilir Kalkınma Hedefine/Hedeflerine katkıda bulunur

SKH 3 Sağlık ve Kaliteli Yaşam

Belgeye Erişim

10.1016/j.annonc.2022.04.118

Diger dosyalar ve linkler

View record in Web of Science

Bundan alıntı yap

Andre, T., Sposetti, C., Gumus, M., Ahn, J. B., Wyrwicz, L., Kwiatkowski, M., Kim, J., Yalcin, S., Sendur, M., Odeleye-Ajakaye, A., Leconte, P., Fogelman, D., & Kim, T. (2022). Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer. Annals of Oncology, 33, S256-S257. https://doi.org/10.1016/j.annonc.2022.04.118

@article{b36d5de2cef34029b20743ee65029375,

title = "Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer",

author = "T. Andre and C. Sposetti and M. Gumus and Ahn, \{J. Bae\} and L. Wyrwicz and M. Kwiatkowski and J. Kim and S. Yalcin and M. Sendur and A. Odeleye-Ajakaye and P. Leconte and D. Fogelman and T. Kim",

year = "2022",

month = jun,

doi = "10.1016/j.annonc.2022.04.118",

language = "English",

volume = "33",

pages = "S256--S257",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

note = "ESMO 24th World Congress on Gastrointestinal Cancer ; Conference date: 29-06-2022 Through 02-07-2022",

}

Andre, T, Sposetti, C, Gumus, M, Ahn, JB, Wyrwicz, L, Kwiatkowski, M, Kim, J, Yalcin, S, Sendur, M, Odeleye-Ajakaye, A, Leconte, P, Fogelman, D & Kim, T 2022, 'Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer', Annals of Oncology, hac. 33, pp. S256-S257. https://doi.org/10.1016/j.annonc.2022.04.118

TY - JOUR

T1 - Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer

AU - Andre, T.

AU - Sposetti, C.

AU - Gumus, M.

AU - Ahn, J. Bae

AU - Wyrwicz, L.

AU - Kwiatkowski, M.

AU - Kim, J.

AU - Yalcin, S.

AU - Sendur, M.

AU - Odeleye-Ajakaye, A.

AU - Leconte, P.

AU - Fogelman, D.

AU - Kim, T.

PY - 2022/6

Y1 - 2022/6

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000823826500041&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1016/j.annonc.2022.04.118

DO - 10.1016/j.annonc.2022.04.118

M3 - Meeting Abstract

SN - 0923-7534

VL - 33

SP - S256-S257

JO - Annals of Oncology

JF - Annals of Oncology

T2 - ESMO 24th World Congress on Gastrointestinal Cancer

Y2 - 29 June 2022 through 2 July 2022

ER -